跳至主要内容
临床试验/EUCTR2020-004878-22-FR
EUCTR2020-004878-22-FR进行中(未招募)1 期

Pharmacokinetic and Placental Transfer of Levetiracetam - EPICEINTE

ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS0 个研究点目标入组 50 人开始时间: 2020年12月3日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • - Pregnant women of childbearing age who are pregnant
  • - Age =18 years
  • - Women with epilepsy treated with levetiracetam in monotherapy or combination
  • - Affiliated to a social security scheme (or entitled)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 50
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Women treated with antiepileptics for pathology other than epilepsy
  • - Women treated with a combination of more than 3 antiepileptics
  • - Severe anemia
  • - Renal failure (moderate to severe)
  • - Hepatic impairment (moderate to severe)
  • - Alcohol and/or recreational drug use
  • - Trend towards non-compliance with treatment
  • - Inability to maintain a Crisis Observation Workbook
  • - Suicidal Ideas
  • - Uncontrolled thyroid disease
  • - Woman under tutorship or curatorship
  • - Patient under state medical assistance (AME)

研究者

相似试验